Evidence map›Paper›PMID 26141042›Full record

ArticleMedical microbiology and immunology2016

Frequency and subtype of BK virus infection in Iranian patients infected with HIV.

Shahla Akhgari, Minoo Mohraz, Kayhan Azadmanesh, Rouhollah Vahabpour, Monireh Kazemimanesh, Arezoo Aghakhani, Manizheh Jozpanahi, Mohammad Banifazl, Anahita Bavand, Amitis Ramezani

Abstract read
PubMed Publisher
In one paragraph

Article in Medical microbiology and immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. BK Viremia among Iranian Renal Transplant Candidates.Iranian journal of pathology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Shahla AkhgariPayame Noor University of Tehran Shargh, Tehran, Iran. shahla_akhgari@yahoo.com.
Minoo MohrazIranian Research Center for HIV/AIDS, Tehran, Iran. minoomohraz@ams.ac.ir.
Kayhan AzadmaneshVirology Department, Pasteur Institute of Iran, Tehran, Iran. azadmanesh@pasteur.ac.ir.
Rouhollah VahabpourHepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran. farhang_v_r@yahoo.com.
Monireh KazemimaneshVirology Department, Pasteur Institute of Iran, Tehran, Iran. kazemim1362@yahoo.com.
Arezoo AghakhaniClinical Research Department, Pasteur Institute of Iran, 13164, Pasteur Ave., Tehran, Iran. araghakhani@hotmail.com.
Manizheh JozpanahiZanjan University of Medical Sciences, Zanjan, Iran. dr.panahi48@gmail.com.
Mohammad BanifazlIranian Society for Support of Patients with Infectious Disease, Tehran, Iran. mohammadbanifazl@aol.com.
Anahita BavandClinical Research Department, Pasteur Institute of Iran, 13164, Pasteur Ave., Tehran, Iran. anahita.bavand@gmail.com.
Amitis RamezaniClinical Research Department, Pasteur Institute of Iran, 13164, Pasteur Ave., Tehran, Iran. amitisramezani@hotmail.com.
Pasteur Institute of Iran · IRIranian Center for Quantum Technologies · IRPayame Noor University · IRZanjan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human polyomavirus BK virus (BKV) is a double-stranded DNA virus that infects approximately 90 % of the general population as a subclinical or mild infection. In immunosuppressed patients, such as HIV cases, BKV may be reactivated resulting hemorrhagic cystitis and tubulointerstitial nephritis. However, there are limited studies on prevalence and molecular epidemiology of BKV in Iran. We therefore aimed to evaluate the prevalence and subtypes of BKV in Iranian HIV patients. A total of 99 patients with HIV infection were enrolled in the study. Presence of BKV DNA in plasma was evaluated by nested PCR. PCR products were sequenced directly, and phylogenetic analysis was performed. BKV DNA was detected in 8.08 % of HIV patients. BKV viremia presented in 4 out of 25 patients (16 %) not receiving antiretroviral therapy in comparison with 4 out 74 of HAART-treated patients (5.4 %) (P = 0.023). In patients with CD4 counts ≥200 cells/mm(3), viremia was found more commonly (7/80 = 8.8 %) than in those with lower counts (1/19 = 5.2 %) (not significant). All sequenced BKV isolates belonged to subtype Ib-2. Our findings indicated that the prevalence of BKV viremia is relatively prevalent in patients with HIV infection and significantly higher in naïve than HAART-treated cases. Therefore, HAART can eliminate BKV infection from plasma and reduce viremia although the actual implication of BKV viremia in HIV patients is not clear.

Indexed as

AdultBK VirusCross-Sectional StudiesDNA, ViralFemaleGenotypeHIV InfectionsHumansIranMaleMiddle AgedMolecular EpidemiologyMolecular Sequence DataPolyomavirus InfectionsPrevalenceSequence Analysis, DNADNA, ViralBK virus (BKV)Human immunodeficiency virus (HIV)PrevalenceSubtype

Identifiers

PMID26141042
OpenAlexW749601312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.